Cargando…
Therapeutic potential of HMGB1-targeting agents in sepsis
Sepsis refers to a systemic inflammatory response syndrome resulting from a microbial infection. The inflammatory response is partly mediated by innate immune cells (such as macrophages, monocytes and neutrophils), which not only ingest and eliminate invading pathogens but also initiate an inflammat...
Autores principales: | Wang, Haichao, Zhu, Shu, Zhou, Rongrong, Li, Wei, Sama, Andrew E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586610/ https://www.ncbi.nlm.nih.gov/pubmed/18980707 http://dx.doi.org/10.1017/S1462399408000884 |
Ejemplares similares
-
A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1
por: Li, Wei, et al.
Publicado: (2007) -
Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review
por: Zhu, Cassie Shu, et al.
Publicado: (2021) -
Pathogenic role of HMGB1 in SARS?
por: Chen, Guoqian, et al.
Publicado: (2004) -
HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
por: Chen, Ruochan, et al.
Publicado: (2020) -
Novel Mechanisms of Herbal Therapies for Inhibiting HMGB1 Secretion or Action
por: Wu, Andrew H., et al.
Publicado: (2015)